Stock 2186 LUYE PHARMA GROUP LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Luye Pharma Group Ltd.

Equities

2186

BMG570071099

Delayed Hong Kong S.E.
Other stock markets
 01:46:24 2024-04-29 am EDT 		5-day change 1st Jan Change
2.71 HKD -0.37% Intraday chart for Luye Pharma Group Ltd. +2.26% -27.08%
Mar. 27 Luye Pharma Group Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 07 Luye Pharma Group Announces the Launch of Its Innovative Drug Zepzelca® (Lurbinectedin) for the Treatment of SCLC in Both Hong Kong and Macao CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Luye Pharma's Lung Cancer Injectable Treatment Shows 45% Response Rate in Trial
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2186 Stock
  4. News Luye Pharma Group Ltd.
  5. Analyst Reco.